MedTrace Logo

Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

NCT03385551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-02-11

No results posted yet for this study

Summary

This is a study to evaluate the acceptability, efficacy and preferences of 10 of estradiol vaginal tablets vs promestriene vaginal cream

Conditions

  • Vulvovaginal Atrophy

Interventions

DRUG

Estradiol

Estradiol or Promestriene depending on the arm

Sponsors & Collaborators

  • Instituto Palacios

    lead OTHER

Principal Investigators

  • Santiago Palacios, MD · Instituto Palacios

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-09
Primary Completion
2020-06-30
Completion
2020-09-30

Countries

  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03385551 on ClinicalTrials.gov